A detailed history of Federated Hermes, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 442,924 shares of PACB stock, worth $797,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
442,924
Previous 446,854 0.88%
Holding current value
$797,263
Previous $612,000 22.88%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $4,716 - $8,528
-3,930 Reduced 0.88%
442,924 $752,000
Q2 2024

Aug 08, 2024

BUY
$1.36 - $3.65 $607,721 - $1.63 Million
446,854 New
446,854 $612,000
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $275,853 - $466,905
-33,518 Reduced 99.94%
19 $0
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $334,353 - $471,180
33,536 Added 3353600.0%
33,537 $446,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $18,109 - $39,490
-4,608 Reduced 99.98%
1 $1,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $18,528 - $48,071
4,609 New
4,609 $20,000
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $1.32 Million - $2.13 Million
-59,024 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$26.38 - $51.15 $11.1 Million - $21.5 Million
-420,612 Reduced 87.69%
59,024 $1.97 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $1.55 Million - $4.21 Million
147,790 Added 44.54%
479,636 $12.4 Million
Q3 2020

Nov 12, 2020

SELL
$3.61 - $9.87 $4.58 Million - $12.5 Million
-1,268,154 Reduced 79.26%
331,846 $3.28 Million
Q3 2018

Nov 13, 2018

BUY
$3.52 - $5.55 $5.63 Million - $8.88 Million
1,600,000 New
1,600,000 $8.66 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.